Development of FRET Assay into Quantitative and High-throughput Screening Technology Platforms for Protein-Protein Interactions

被引:71
|
作者
Song, Yang [1 ]
Madahar, Vipul [1 ]
Liao, Jiayu [1 ,2 ]
机构
[1] Univ Calif Riverside, Dept Bioengn, Bourns Coll Engn, Riverside, CA 92521 USA
[2] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA
基金
美国国家卫生研究院;
关键词
SUMOylation; Forster resonance energy transfer; K-d affinity determination; High-throughput screening; RESONANCE ENERGY-TRANSFER; SUMO; UBIQUITIN; ENZYME; UBC9; SITE;
D O I
10.1007/s10439-010-0225-x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Forster resonance energy transfer (FRET) technology has been widely used in biological and biomedical research and is a very powerful tool in elucidating protein interactions in many cellular processes. Ubiquitination and SUMOylation are multi-step cascade reactions, involving multiple enzymes and protein-protein interactions. Here we report the development of dissociation constant (K (d)) determination for protein-protein interaction and cell-based high-throughput screening (HTS) assay in SUMOylation cascade using FRET technology. These developments are based on steady state and high efficiency of fluorescent energy transfer between CyPet and YPet fused with SUMO1 and Ubc9, respectively. The developments in theoretical and experimental procedures for protein interaction K (d) determination and cell-based HTS provide novel tools in affinity measurement and protein interaction inhibitor screening. The K (d) determined by FRET between SUMO1 and Ubc9 is compatible with those determined with other traditional approaches, such as isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR). The FRET-based HTS is pioneer in cell-based HTS. Both K (d) determination and cell-based HTS, carried out in 384-well plate format, provide powerful tools for large-scale and high-throughput applications.
引用
收藏
页码:1224 / 1234
页数:11
相关论文
共 50 条
  • [31] Engineering High Affinity Protein-Protein Interactions Using a High-Throughput Microcapillary Array Platform
    Lim, Sungwon
    Chen, Bob
    Kariolis, Mihalis S.
    Dimov, Ivan K.
    Baer, Thomas M.
    Cochran, Jennifer R.
    ACS CHEMICAL BIOLOGY, 2017, 12 (02) : 336 - 341
  • [32] Multiplexed high-throughput screening approach for identification of selective protein-protein interaction modulators
    Garlick, Julie
    Sturlis, Steven
    Mapp, Anna
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [33] Automated High-Throughput Fluorescence Lifetime Imaging Microscopy to Detect Protein-Protein Interactions
    Guzman, Camilo
    Oetken-Lindholm, Christina
    Abankwa, Daniel
    JALA, 2016, 21 (02): : 238 - 245
  • [34] High-throughput methods for identification of protein-protein interactions involving short linear motifs
    Cecilia Blikstad
    Ylva Ivarsson
    Cell Communication and Signaling, 13
  • [35] New homogeneous high-throughput assays for inhibitors of β-catenin/Tcf protein-protein interactions
    Zhang, Min
    Huang, Zheng
    Yu, Binxun
    Ji, Haitao
    ANALYTICAL BIOCHEMISTRY, 2012, 424 (01) : 57 - 63
  • [36] Proteome-wide prediction of protein-protein interactions from high-throughput data
    Liu, Zhi-Ping
    Chen, Luonan
    PROTEIN & CELL, 2012, 3 (07) : 508 - 520
  • [37] High-throughput methods for identification of protein-protein interactions involving short linear motifs
    Blikstad, Cecilia
    Ivarsson, Ylva
    CELL COMMUNICATION AND SIGNALING, 2015, 13
  • [38] Proteome-wide prediction of protein-protein interactions from high-throughput data
    ZhiPing Liu
    Luonan Chen
    Protein & Cell, 2012, 3 (07) : 508 - 520
  • [39] A High-Throughput Screening Strategy for Development of RNF8-Ubc13 Protein-Protein Interaction Inhibitors
    Weber, Elisabeth
    Rothenaigner, Ina
    Brandner, Stefanie
    Hadian, Kamyar
    Schorpp, Kenji
    SLAS DISCOVERY, 2017, 22 (03) : 316 - 323
  • [40] Develop quantitative FRET (qFRET) technology as a high-throughput universal assay platform for basic quantitative biomedical and translational research and development
    Jiayu Liao
    Med-X, 1 (1):